Print Page   |   Contact Us   |   Your Cart   |   Sign In
Sign In

Breaking News

5/31/2018 » 6/3/2018
2018 OSAP Annual Conference

OSAP 2015 Symposium Federal Compliance Agency Briefing

OSAP 2015 Symposium: Infection Control - Gaining the Edge

TITLE    Federal Compliance Agency Briefing




a. CDC - This presentation will reinforce the effectiveness of the Guidelines for Infection Control in Dental Health-Care Settings—2003 and review upcoming products to be released later this year.

b. EPA - An overview of EPA’s regulatory authority as it pertains to antimicrobial products (disinfectants) will be provided. The discussion will place emphasis on product claims for the treatment of surfaces contaminated with bacterial biofilm. EPA’s perspective on biofilm methodology, potential label claims, and the technical aspects under consideration for regulatory guidance will be provided during the session. 

c. FDA - To help practitioners and industry understand the regulatory framework of the Food and Drug Administration. Particularly the Dental Devices Branch located within the Center for Devices and Radiological Health of the FDA. Participants will also be able to understand the issues that are similar between agencies and how the agencies delegate responsibility for certain regulatory actions. Specific issues that FDA will address include: reuse of medical devices, and infection control issues relative to multi- use dispensers.

d. HRSA - This presentation will provide an overview of the Health Resources and Services Administration (HRSA), an Operating Division of the U.S. Department of Health and Human Services, the primary Federal agency for improving access to health care services for people who are uninsured, isolated or medically vulnerable and will focus on oral health programs and initiatives.

e. OSHA - An overview of OSHA standards with a focus on the Bloodborne Pathogen Standard (29 CFR 1910.1030). Information will include injury/illness data by industry, the top 10 cited standards in general industry, the top 10 cited standards within healthcare settings, and a discussion of the General Duty Clause.





a. Jennifer Cleveland DDS MPH

b. Stephen Tomasino PhD

c. Susan Runner DDS, MA

d. Renee Joskow DDS, MPH

e. Michael Pannell PhD, CIH





After attending this program, participants should be able to:

a. CDC

  • Understand the role of CDC in disease prevention.
  • Describe recent transmissions of bloodborne pathogens in dental settings.
  • Understand the importance of complying with Standard Precautions in preventing transmission.

b. EPA

  • Explain EPA’s regulatory authority as it pertains to antimicrobial pesticides.
  • Describe EPA’s emphasis on test method performance as it pertains to biofilm methods
  • Describe the use of standardized test methods for supporting specific biofilm claims.

c. FDA

  • Have a general concept of the mission and responsibilities of the FDA relative to Dental Devices.
  • Identify and name the types interactions and cooperative activities of various federal regulatory agencies
  • Classify the activities of various federal regulatory agencies.


  • Describe HRSA’s mission 
  • Identify HRSA programs that improve oral health access
  • List HRSA’s Goals


  • Participants will be able to state the top 10 cited OSHA standard within general industry and within healthcare settings.
  • Participants will be able to state the requirements necessary to cite under the General Duty Clause.





OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2018. Sponsorship does not imply endorsement by OSAP of a company's products or services.